vs
Side-by-side financial comparison of Getty Images Holdings, Inc. (GETY) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $282.3M, roughly 1.7× Getty Images Holdings, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -32.2%, a 39.0% gap on every dollar of revenue. On growth, Getty Images Holdings, Inc. posted the faster year-over-year revenue change (14.1% vs -1.7%). Over the past eight quarters, Getty Images Holdings, Inc.'s revenue compounded faster (12.7% CAGR vs -0.1%).
Getty Images Holdings, Inc. is a visual media company and supplier of stock images, editorial photography, video, and music for businesses and consumers, with a library of over 477 million assets. It targets three markets—creative professionals, the media, and corporate.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
GETY vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $282.3M | $493.8M |
| Net Profit | $-90.9M | $33.7M |
| Gross Margin | 74.8% | — |
| Operating Margin | -8.5% | 9.9% |
| Net Margin | -32.2% | 6.8% |
| Revenue YoY | 14.1% | -1.7% |
| Net Profit YoY | -467.6% | 10.5% |
| EPS (diluted) | $-0.22 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $282.3M | $493.8M | ||
| Q3 25 | $240.0M | $492.9M | ||
| Q2 25 | $234.9M | $468.8M | ||
| Q1 25 | $224.1M | $458.4M | ||
| Q4 24 | $247.3M | $502.4M | ||
| Q3 24 | $240.5M | $511.2M | ||
| Q2 24 | $229.1M | $504.3M | ||
| Q1 24 | $222.3M | $495.1M |
| Q4 25 | $-90.9M | $33.7M | ||
| Q3 25 | $21.6M | $71.7M | ||
| Q2 25 | $-34.4M | $39.3M | ||
| Q1 25 | $-102.6M | $20.7M | ||
| Q4 24 | $24.7M | $30.5M | ||
| Q3 24 | $-2.5M | $19.4M | ||
| Q2 24 | $3.7M | $-153.0M | ||
| Q1 24 | $13.6M | $4.0M |
| Q4 25 | 74.8% | — | ||
| Q3 25 | 73.2% | — | ||
| Q2 25 | 72.1% | — | ||
| Q1 25 | 73.1% | — | ||
| Q4 24 | 73.5% | — | ||
| Q3 24 | 73.4% | — | ||
| Q2 24 | 72.5% | — | ||
| Q1 24 | 72.9% | — |
| Q4 25 | -8.5% | 9.9% | ||
| Q3 25 | 18.8% | 13.8% | ||
| Q2 25 | 15.1% | 12.8% | ||
| Q1 25 | 12.2% | 7.0% | ||
| Q4 24 | 14.5% | 7.8% | ||
| Q3 24 | 23.9% | 6.6% | ||
| Q2 24 | 20.3% | -31.3% | ||
| Q1 24 | 18.5% | 3.2% |
| Q4 25 | -32.2% | 6.8% | ||
| Q3 25 | 9.0% | 14.5% | ||
| Q2 25 | -14.6% | 8.4% | ||
| Q1 25 | -45.8% | 4.5% | ||
| Q4 24 | 10.0% | 6.1% | ||
| Q3 24 | -1.1% | 3.8% | ||
| Q2 24 | 1.6% | -30.3% | ||
| Q1 24 | 6.1% | 0.8% |
| Q4 25 | $-0.22 | $0.40 | ||
| Q3 25 | $0.05 | $0.84 | ||
| Q2 25 | $-0.08 | $0.46 | ||
| Q1 25 | $-0.25 | $0.24 | ||
| Q4 24 | $0.07 | $0.37 | ||
| Q3 24 | $-0.01 | $0.23 | ||
| Q2 24 | $0.01 | $-1.84 | ||
| Q1 24 | $0.03 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.2M | $375.2M |
| Total DebtLower is stronger | $1.3B | $570.5M |
| Stockholders' EquityBook value | $552.5M | $865.9M |
| Total Assets | $3.2B | $2.2B |
| Debt / EquityLower = less leverage | 2.30× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.2M | $375.2M | ||
| Q3 25 | $109.5M | $340.1M | ||
| Q2 25 | $110.3M | $224.7M | ||
| Q1 25 | $114.6M | $99.0M | ||
| Q4 24 | $121.2M | $229.9M | ||
| Q3 24 | $109.9M | $103.8M | ||
| Q2 24 | $121.7M | $19.4M | ||
| Q1 24 | $134.2M | $8.0M |
| Q4 25 | $1.3B | $570.5M | ||
| Q3 25 | $1.3B | $577.2M | ||
| Q2 25 | $1.3B | $583.9M | ||
| Q1 25 | $1.3B | $590.5M | ||
| Q4 24 | $1.3B | $597.1M | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $552.5M | $865.9M | ||
| Q3 25 | $634.6M | $890.7M | ||
| Q2 25 | $611.2M | $833.8M | ||
| Q1 25 | $593.0M | $789.2M | ||
| Q4 24 | $670.2M | $764.9M | ||
| Q3 24 | $683.4M | $732.5M | ||
| Q2 24 | $654.0M | $706.5M | ||
| Q1 24 | $640.8M | $856.2M |
| Q4 25 | $3.2B | $2.2B | ||
| Q3 25 | $2.6B | $2.2B | ||
| Q2 25 | $2.6B | $2.1B | ||
| Q1 25 | $2.6B | $2.0B | ||
| Q4 24 | $2.6B | $2.2B | ||
| Q3 24 | $2.6B | $2.1B | ||
| Q2 24 | $2.6B | $2.0B | ||
| Q1 24 | $2.6B | $2.2B |
| Q4 25 | 2.30× | 0.66× | ||
| Q3 25 | 2.11× | 0.65× | ||
| Q2 25 | 2.19× | 0.70× | ||
| Q1 25 | 2.21× | 0.75× | ||
| Q4 24 | 1.96× | 0.78× | ||
| Q3 24 | 1.97× | — | ||
| Q2 24 | 2.06× | — | ||
| Q1 24 | 2.16× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.6M | $114.1M |
| Free Cash FlowOCF − Capex | $7.7M | — |
| FCF MarginFCF / Revenue | 2.7% | — |
| Capex IntensityCapex / Revenue | 4.6% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $5.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.6M | $114.1M | ||
| Q3 25 | $22.6M | $137.3M | ||
| Q2 25 | $6.5M | $137.2M | ||
| Q1 25 | $15.4M | $-117.5M | ||
| Q4 24 | $39.7M | $133.0M | ||
| Q3 24 | $10.7M | $91.8M | ||
| Q2 24 | $46.4M | $107.0M | ||
| Q1 24 | $21.5M | $-125.2M |
| Q4 25 | $7.7M | — | ||
| Q3 25 | $7.9M | — | ||
| Q2 25 | $-9.6M | — | ||
| Q1 25 | $-322.0K | — | ||
| Q4 24 | $24.6M | — | ||
| Q3 24 | $-1.8M | — | ||
| Q2 24 | $31.1M | — | ||
| Q1 24 | $7.1M | — |
| Q4 25 | 2.7% | — | ||
| Q3 25 | 3.3% | — | ||
| Q2 25 | -4.1% | — | ||
| Q1 25 | -0.1% | — | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | -0.8% | — | ||
| Q2 24 | 13.6% | — | ||
| Q1 24 | 3.2% | — |
| Q4 25 | 4.6% | — | ||
| Q3 25 | 6.1% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 7.0% | — | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 6.7% | — | ||
| Q1 24 | 6.5% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | 1.05× | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | 1.61× | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | 12.59× | — | ||
| Q1 24 | 1.58× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GETY
| Creative | $149.0M | 53% |
| Editorial | $109.4M | 39% |
| Other | $23.9M | 8% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
